Daiichinkyo Co (TSE:4568) Days Inventory

: 286.72 (As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

Days Inventory is also known as Days Sales of Inventory (DSI). Daiichinkyo Co's Average Total Inventories for the three months ended in Dec. 2023 was 円384,432 Mil. Daiichinkyo Co's Cost of Goods Sold for the three months ended in Dec. 2023 was 円122,347 Mil. Hence, Daiichinkyo Co's Days Inventory for the three months ended in Dec. 2023 was 286.72.

The historical rank and industry rank for Daiichinkyo Co's Days Inventory or its related term are showing as below:

TSE:4568' s Days Inventory Range Over the Past 10 Years
Min: 155.36 Med: 188.79 Max: 293.66
Current: 293.66

During the past 13 years, Daiichinkyo Co's highest Days Inventory was 293.66. The lowest was 155.36. And the median was 188.79.

TSE:4568's Days Inventory is ranked worse than
83.79% of 975 companies
in the Drug Manufacturers industry
Industry Median: 157.96 vs TSE:4568: 293.66

Daiichinkyo Co's Days Inventory increased from Dec. 2022 (246.26) to Dec. 2023 (286.72). It might indicate that Daiichinkyo Co's sales slowed down.

Inventory Turnover measures how fast the company turns over its inventory within a year. Daiichinkyo Co's Inventory Turnover for the three months ended in Dec. 2023 was 0.32.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Daiichinkyo Co's Inventory-to-Revenue for the three months ended in Dec. 2023 was 0.86.

Daiichinkyo Co Days Inventory Historical Data

The historical data trend for Daiichinkyo Co's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Daiichinkyo Co Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Days Inventory

Get a 7-Day Free Trial

174.52

185.81

201.89

216.26

260.81

Daiichinkyo Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Inventory	Get a 7-Day Free Trial															246.26	244.64	312.14	345.26	286.72

Competitive Comparison

For the Drug Manufacturers - General subindustry, Daiichinkyo Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Daiichinkyo Co Days Inventory Distribution

For the Drug Manufacturers industry and Healthcare sector, Daiichinkyo Co's Days Inventory distribution charts can be found below:

* The bar in red indicates where Daiichinkyo Co's Days Inventory falls into.

Daiichinkyo Co Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Daiichinkyo Co's Days Inventory for the fiscal year that ended in Mar. 2023 is calculated as

	Days Inventory (A: Mar. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Mar. 2022 )	+	Total Inventories (A: Mar. 2023 ))	/	count )	/	Cost of Goods Sold (A: Mar. 2023 )	*	Days in Period
=	( (217910	+	301608)	/	2 )	/	363526	*	365
=	259759					/	363526	*	365
=	260.81

Daiichinkyo Co's Days Inventory for the quarter that ended in Dec. 2023 is calculated as:

	Days Inventory (Q: Dec. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Sep. 2023 )	+	Total Inventories (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (377631	+	391232)	/	2 )	/	122347	*	365 / 4
=	384431.5					/	122347	*	365 / 4
=	286.72

Daiichinkyo Co (TSE:4568) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Daiichinkyo Co's Inventory Turnover for the three months ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	122347	/	384431.5
	=	0.32

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Daiichinkyo Co's Inventory to Revenue for the three months ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	384431.5	/	446925
	=	0.86

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Daiichinkyo Co Days Inventory Related Terms

Thank you for viewing the detailed overview of Daiichinkyo Co's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Daiichinkyo Co (TSE:4568) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Daiichi Sankyo Co Ltd (TSE:4568) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

DSNKY:USA DSKYF:USA D4S:Germany

Address

3-5-1, Nihonbashi-honcho, Chuo-ku, Tokyo, JPN, 103-8426

Website

https://www.daiichisankyo.com

Daiichi Sankyo was established by the merger of Daiichi Pharmaceuticals and Sankyo in 2005. As of 2021, approximately half of revenue comes from its Japan businesses, which will shrink in the future as the company expands its global footprint. Its primary growth driver is its leading platform of antibody drug conjugates. Its three lead ADCs are Enhertu (HER2), Dato-DXd (TROP2), I-DXd (B7-H3), HER3-DXd (HER3), and R-DXd (CDH6). Enhertu entered the clinic in 2015 and received its first U.S approval in December 2019 for third-line late-stage HER2-positive breast cancer. It is also approved for HER2-positive stomach cancers and HER2 mutant non-small cell lung cancer.

Daiichinkyo Co (TSE:4568) Headlines

No Headlines